Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter C Smits

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Circulation|December 24, 2003
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Patrick W Serruys, Ron T van Domburg, et al.
American Heart Journal|April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trialGeorgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Journal of the American College of Cardiology|May 23, 2025
Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR PatientsDario Bongiovanni, Antonio Landi, Enrico Frigoli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trialClemens von Birgelen, Taku Asano, Giovanni Amoroso, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Lancet (London, England)|October 31, 2024
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trialDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
JACC. Cardiovascular Interventions|June 25, 2016
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II TrialYohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, et al.
Circulation|March 23, 2005
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH)Marco Valgimigli, Carlos A G van Mieghem, Andrew T L Ong, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Circulation|December 24, 2003
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Patrick W Serruys, Ron T van Domburg, et al.
American Heart Journal|April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trialGeorgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Journal of the American College of Cardiology|May 23, 2025
Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR PatientsDario Bongiovanni, Antonio Landi, Enrico Frigoli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trialClemens von Birgelen, Taku Asano, Giovanni Amoroso, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Lancet (London, England)|October 31, 2024
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trialDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
JACC. Cardiovascular Interventions|June 25, 2016
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II TrialYohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, et al.
Circulation|March 23, 2005
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH)Marco Valgimigli, Carlos A G van Mieghem, Andrew T L Ong, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Pageof 19